Phase II Study Exploring Efficacy and Safety of Iodinated Activated Charcoal in COPD.

Trial Profile

Phase II Study Exploring Efficacy and Safety of Iodinated Activated Charcoal in COPD.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Nov 2013

At a glance

  • Drugs Charcoal; Iodine
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Feb 2013 Planned end date changed from 1 Oct 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
    • 11 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 10 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top